Literature DB >> 33434418

Clinical and echocardiography predictors of response to inhaled nitric oxide in hypoxemic term and near-term neonates.

Adrianne R Bischoff1, Regan E Giesinger1, Elaine Neary2, Dany E Weisz3, Jaques Belik4, Patrick J McNamara1,5.   

Abstract

Approximately 40% of hypoxemic term/near-term neonates are nonresponders to inhaled nitric oxide (iNO). Phenotypic characterization of patients less likely to respond may improve diagnostic precision and therapeutic decisions. We conducted a retrospective cohort study of neonates born ≥35 weeks gestation with hypoxemia who received iNO in the first 72 h of life and classified them into responders and nonresponders according to changes in the fraction of inspired oxygen, saturations and/or arterial partial pressure of oxygen after 1 h of administration. Comprehensive targeted neonatal echocardiography (TnECHO) data were collected when performed up to 6 h prior or 24 h after iNO initiation. Descriptive statistics, univariate analysis, and binary logistic regression were used to compare the groups. There were 183 patients included (63% responders) and TnECHO was performed in 54 infants. The presence of lung disease, and particularly meconium aspiration syndrome (p = .004), was associated with nonresponse to iNO. Nonresponders were characterized by a higher need for rescue high-frequency ventilation (p < .001), longer duration of mechanical ventilation (p < .001), and need for oxygen support (p = .003). Pulmonary hypertension documented on TnECHO was present in 96.3% of the patients but there was no difference in frequency or severity of pulmonary hypertension, or rates of low cardiac output between the groups. Moderate-to-severe right ventricular systolic dysfunction (p > .05) and lower left ventricular strain (p < .05) were more likely in the nonresponder group. In summary, response to iNO is influenced by lung disease, choice of ventilation strategy, and perhaps underlying cardiovascular physiology. Prospective pre- and post-iNO echocardiography data may provide novel physiologic insights.
© 2021 Wiley Periodicals LLC.

Entities:  

Keywords:  inhaled nitric oxide; neonate; pulmonary hypertension; targeted neonatal echocardiography

Year:  2021        PMID: 33434418     DOI: 10.1002/ppul.25252

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  2 in total

1.  [Early risk factors for death in neonates with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide].

Authors:  Ai-Min Qian; Wen Zhu; Yang Yang; Ke-Yu Lu; Jia-Li Wang; Xu Chen; Chu-Chu Guo; Ya-Dong Lu; Hui Rong; Rui Chneg
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-05-15

2.  Short-term ventriculo-arterial coupling and myocardial work efficiency in preterm infants undergoing percutaneous patent ductus arteriosus closure.

Authors:  Adrianne R Bischoff; Amy H Stanford; Patrick J McNamara
Journal:  Physiol Rep       Date:  2021-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.